[PHARMA] YoY Annual (Unaudited) Result on 31-Dec-2010 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
25-Feb-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2010
Quarter
31-Dec-2010 [#4]
Profit Trend
YoY- -49.52%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annual (Unaudited) Result
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Revenue 1,946,639 1,812,346 1,520,981 1,378,348 1,300,796 1,305,646 1,183,983 8.63%
PBT 92,997 103,313 73,186 45,462 81,436 90,599 77,898 2.99%
Tax -36,236 -40,108 -20,401 -15,152 -19,709 -29,190 -26,180 5.56%
NP 56,761 63,205 52,785 30,310 61,727 61,409 51,718 1.56%
-
NP to SH 55,200 61,710 52,157 30,384 60,191 60,031 50,080 1.63%
-
Tax Rate 38.96% 38.82% 27.88% 33.33% 24.20% 32.22% 33.61% -
Total Cost 1,889,878 1,749,141 1,468,196 1,348,038 1,239,069 1,244,237 1,132,265 8.90%
-
Net Worth 486,754 471,886 514,273 421,524 431,158 388,297 349,768 5.65%
Dividend
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Div 41,477 41,187 35,304 10,698 39,585 28,881 19,253 13.63%
Div Payout % 75.14% 66.74% 67.69% 35.21% 65.77% 48.11% 38.45% -
Equity
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Net Worth 486,754 471,886 514,273 421,524 431,158 388,297 349,768 5.65%
NOSH 258,911 117,677 117,682 106,985 106,987 106,968 106,962 15.85%
Ratio Analysis
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
NP Margin 2.92% 3.49% 3.47% 2.20% 4.75% 4.70% 4.37% -
ROE 11.34% 13.08% 10.14% 7.21% 13.96% 15.46% 14.32% -
Per Share
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
RPS 751.85 1,540.10 1,292.44 1,288.35 1,215.84 1,220.58 1,106.91 -6.23%
EPS 21.32 52.44 44.32 28.40 56.26 56.12 46.82 -12.27%
DPS 16.02 35.00 30.00 10.00 37.00 27.00 18.00 -1.92%
NAPS 1.88 4.01 4.37 3.94 4.03 3.63 3.27 -8.80%
Adjusted Per Share Value based on latest NOSH - 106,919
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
RPS 135.07 125.75 105.53 95.64 90.25 90.59 82.15 8.63%
EPS 3.83 4.28 3.62 2.11 4.18 4.17 3.47 1.65%
DPS 2.88 2.86 2.45 0.74 2.75 2.00 1.34 13.58%
NAPS 0.3377 0.3274 0.3568 0.2925 0.2992 0.2694 0.2427 5.65%
Price Multiplier on Financial Quarter End Date
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Date 31/12/13 31/12/12 30/12/11 30/12/10 31/12/09 31/12/08 31/12/07 -
Price 4.45 8.10 5.36 5.31 4.00 3.36 2.93 -
P/RPS 0.59 0.53 0.41 0.41 0.33 0.28 0.26 14.61%
P/EPS 20.87 15.45 12.09 18.70 7.11 5.99 6.26 22.20%
EY 4.79 6.47 8.27 5.35 14.07 16.70 15.98 -18.17%
DY 3.60 4.32 5.60 1.88 9.25 8.04 6.14 -8.50%
P/NAPS 2.37 2.02 1.23 1.35 0.99 0.93 0.90 17.49%
Price Multiplier on Announcement Date
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Date 24/02/14 18/02/13 22/02/12 25/02/11 19/02/10 27/02/09 28/02/08 -
Price 4.29 7.80 5.90 5.35 4.05 2.73 2.98 -
P/RPS 0.57 0.51 0.46 0.42 0.33 0.22 0.27 13.24%
P/EPS 20.12 14.87 13.31 18.84 7.20 4.86 6.36 21.13%
EY 4.97 6.72 7.51 5.31 13.89 20.56 15.71 -17.43%
DY 3.73 4.49 5.08 1.87 9.14 9.89 6.04 -7.71%
P/NAPS 2.28 1.95 1.35 1.36 1.00 0.75 0.91 16.52%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment